Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: Comparison with PET and enhanced CT

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 36, Issue 3, 2009, Pages 362-372

  Kitajima, Kazuhiro ^a,e   Murakami, Koji ^a   Yamasaki, Erena ^a   Domeki, Yasushi ^a   Kaji, Yasushi ^a   Morita, Satoru ^b   Suganuma, Narufumi ^c   Sugimura, Kazuro ^d  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c KOCHI MEDICAL SCHOOL   (Japan)

^d KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e Kobe University Graduate School of Medicine ^*  (Japan)

Author keywords

FDG; PET CT; Recurrence; Uterine cancer

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOMEPROL; IOMEPROLE 300; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; INTEGRATED POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; UTERUS CANCER;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED; UTERINE NEOPLASMS;

EID: 60549110475     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-008-0956-1     Document Type: Article

References (40)

1. DM Larson LJ Copeland CA Stringer DM Gershenson JM Malone Jr CL Edwards 1988 Recurrent cervical carcinoma after radical hysterectomy Gynecol Oncol 30 381 387
2. WP Irvin LW Rice RS Berkowitz 2002 Advances in the management of endometrial adenocarcinoma. A review J Reprod Med 47 173 190
3. SS Lo US Khoo DK Cheng TY Ng LC Wong HY Ngan 1999 Role of serial markers in the surveillance for recurrence in endometrial cancer Cancer Detect Prev 23 397 400
4. RN Low JS Sigeti 1994 MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging AJR Am J Roentgenol 163 1131 1140
5. T Sugiyama T Nishida K Ushijima N Sato A Kataoka K Imaishi 1995 Detection of lymph node metastasis in ovarian carcinoma and uterine corpus carcinoma by preoperative computerized tomography or magnetic resonance imaging J Obstet Gynaecol 21 551 556
6. JP Connor JI Andrews B Anderson RE Buller 2000 Computed tomography in endometrial carcinoma Obstet Gynecol 95 692 696
7. HK Pannu EK Fishmann 2003 Evaluation of cervical cancer by computed tomography: current status Cancer 98 2039 2043
8. YY Jeong HK Kong TW Chung JJ Seo JG Park 2003 Uterine cervical carcinoma after therapy: CT and MR imaging findings Radiographics 23 968 981
9. HK Pannu RE Bristow FJ Montz EK Fishman 2003 Multidetector CT of peritoneal carcinomatosis from ovarian cancer Radiographics 23 687 701
10. GJ Cook MN Maisey I Fogelman 1999 Normal variants, artifacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine Eur J Nucl Med 26 1363 1378
11. L Kostakoglu H Agress Jr SJ Goldsmith 2003 Clinical role of FDG PET in evaluation of cancer patients Radiographics 23 315 340
12. T Beyer DW Townsend T Brun PE Kinahan M Charron R Roddy 2000 A combined PET/CT scanner for clinical oncology J Nucl Med 41 1369 1379
13. R Bar-Shalom N Yefremov L Guralnik D Gaitini A Frenkel A Kuten 2003 Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management J Nucl Med 44 1200 1209
14. 18F-FDG PET in patients with cervical cancer J Nucl Med 44 347 352
15. LJ Havrilesky TZ Wong AA Secord A Berchuck DL Clarke-Pearson EL Jones 2003 The role of PET scanning in the detection of recurrent cervical cancer Gynecol Oncol 90 186 190
16. CH Lai KG Huang LC See TC Yen CS Tsai TC Chang 2004 Restaging of recurrent cervical carcinoma with dual-phase [18F]fluoro-2-deoxy-D-glucose positron emission tomography Cancer 100 544 552
17. TC Chang KS Law JH Hong CH Lai KK Ng S Hsueh 2004 Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during follow-up for patients with cervical malignancies: a phase II study Cancer 101 164 171
18. TC Yen LC See TC Chang KG Huang KK Ng SG Tang 2004 Defining the priority of using 18F-FDG PET for recurrent cervical cancer J Nucl Med 45 1632 1639
19. T Belhocine C Debarsy R Hustinx J Willems-Foidart 2002 Usefulness of 18F-FDG PET in the post-therapy surveillance of endometrial carcinoma Eur J Nucl Med Mol Imaging 9 1132 1139
20. T Saga T Higashi T Ishimori M Mamede Y Nakamoto T Mukai 2003 Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancer Ann Nucl Med 17 197 203
21. A Chao TC Chang KK Ng S Hsueh HJ Huang HH Chou 2006 18F-FDG PET in the management of endometrial cancer Eur J Nucl Med Mol Imaging 33 36 44
22. HH Chung H Jo WJ Kang JW Kim NH Park YS Song 2007 Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence Gynecol Oncol 104 529 534
23. S Sironi M Picchio C Landoni S Galimberti M Signorelli V Bettinardi 2007 Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in the detection of recurrence Eur J Nucl Med Mol Imaging 34 472 479
24. K Kitajima K Murakami E Yamasaki S Hagiwara I Fukasawa N Inaba 2008 Performance of FDG-PET/CT in the diagnosis of recurrent endometrial cancer Ann Nucl Med 22 103 109
25. Park JY, Kim EN, Kim DY, Suh DS, Kim JH, Kim YM, et al. Clinical impact of positron emission tomography or positron emission tomography/computed tomography in the posttherapy surveillance of endometrial carcinoma: evaluation of 88 patients. Int J Gynecol Cancer 2008; [Epub ahead of print]. doi: 10.1111/j.1525-1438.2008.01197.x
26. HH Chung WJ Kang JW Kim NH Park YS Song JK Chung 2008 The clinical impact of [18F]FDG PET/CT for the management of recurrent endometrial cancer: correlation with clinical and histological findings Eur J Nucl Mol Imaging 35 1081 1088
27. K Kitajima K Murakami E Yamasaki Y Domeki Y Kaji K Sugimura 2008 Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer Eur Radiol 18 2040 2047
28. G Antoch J Stattaus AT Nemat S Marnitz T Beyer H Keuhl 2003 Non-small cell lung cancer: dual-modality PET/CT in preoperative staging Radiology 229 526 533
29. G Antoch N Saoudi H Kuehl G Dahmen SP Mueller T Beyer 2004 Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET J Clin Oncol 22 4357 4368
30. K Kitajima K Murakami E Yamasaki I Fukasawa N Inaba Y Kaji 2008 Accuracy of FDG PET/CT in detecting pelvic and paraaortic lymph node metastasis in patients with endometrial cancer AJR Am J Roentgenol 190 1652 1658
31. A Loft AK Berthelsen H Roed C Ottosen L Lundvall J Knudsen 2007 The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study Gynecol Oncol 106 29 34
32. HK Pannu C Cohade RE Bristow EK Fishman RL Wahl 2004 PET-CT detection of abdominal recurrence of ovarian cancer: radiologic-surgical correlation Abdom Imaging 29 398 403
33. R Manfredi P Mirk G Maresca PA Margariti A Testa GF Zannoni 2004 Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning Radiology 231 372 378
34. AG Rockall SA Sohaib MG Haristinghani SA Babar N Singh AR Jeyarajah 2005 Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer J Clin Oncol 23 2813 2821
35. ER Coleman D Delbeke MJ Guiberteau PS Conti HD Royal JC Weinre 2005 Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance J Nucl Med 46 1225 1239
36. B Rodriguez-Vigil N Gomez-Leon I Pinilla D Hernandez-Maraver J Coya L Martin-Curto 2006 PET/CT in lymphoma: prospective study of enhanced full-dose PET/CT versus unenhanced low-dose PET/CT J Nucl Med 7 1643 1648
37. O Mawlawi JJ Erasmus RF Munden T Pan A Knight HA Macapinlac 2006 Quantifying the effect of IV contrast media on integrated PET/CT: clinical evaluation AJR Am J Roentgenol 186 308 319
38. G Antoch LS Freudenberg T Beyer A Bockisch JF Debatin 2004 To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT J Nucl Med 45 56 65
39. AC Pfannenberg P Aschoff K Brechtel M Muller R Bares F Paulsen 2007 Low dose non-enhanced CT versus standard dose contrast-enhanced CT in combined PET/CT protocols for staging and therapy planning in non-small cell lung cancer Eur J Nucl Med Mol Imaging 34 36 44
40. K Kitajima K Murakami E Yamasaki Y Domeki Y Kaji I Fukasawa 2008 Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET/non-contrast- enhanced CT and enhanced CT Eur J Nucl Med Mol Imaging 35 1439 1448